Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,192 | -62,790 | -47,380 | -37,467 | 79,088 |
| Depreciation Amortization | 516 | 738 | 1,464 | 1,933 | 2,463 |
| Accounts receivable | N/A | N/A | 116 | -116 | 16,000 |
| Accounts payable and accrued liabilities | 928 | 2,194 | 1,542 | -2,032 | -5,668 |
| Other Working Capital | 6,235 | 4,595 | -4,738 | -6,713 | -112,940 |
| Other Operating Activity | 5,102 | 1,128 | 1,696 | 6,196 | -5,753 |
| Operating Cash Flow | $-77,411 | $-54,135 | $-47,300 | $-38,199 | $-26,810 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,884 | -9,438 | 10,019 | -19,666 | 21,503 |
| PPE Investments | -769 | -505 | -690 | -136 | -454 |
| Investing Cash Flow | $-24,653 | $-9,943 | $9,329 | $-19,802 | $21,049 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 13,500 | 0 | 2,000 | 15,000 | 0 |
| Debt Repayment | -2,630 | -4,246 | -579 | -1,834 | -2,179 |
| Common Stock Issued | 58,172 | 119,793 | 35,315 | 31,990 | 50 |
| Common Stock Repurchased | N/A | -32 | N/A | 0 | N/A |
| Financing Cash Flow | $69,042 | $115,515 | $36,736 | $45,156 | $-2,129 |
| Beginning Cash Position | 81,512 | 30,075 | 31,310 | 44,155 | 52,045 |
| End Cash Position | 48,490 | 81,512 | 30,075 | 31,310 | 44,155 |
| Net Cash Flow | $-33,022 | $51,437 | $-1,235 | $-12,845 | $-7,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,411 | -54,135 | -47,300 | -38,199 | -26,810 |
| Capital Expenditure | -769 | -505 | -690 | -136 | -454 |
| Free Cash Flow | -78,180 | -54,640 | -47,990 | -38,335 | -27,264 |